Long-term outcomes of induction chemotherapy followed by chemoradiotherapy vs chemoradiotherapy alone as treatment of unresectable head and neck cancer: follow-up of the Spanish Head and Neck Cancer Group (TTCC) 2503 Trial.

Saved in:

Bibliographic Details
Title:	Long-term outcomes of induction chemotherapy followed by chemoradiotherapy vs chemoradiotherapy alone as treatment of unresectable head and neck cancer: follow-up of the Spanish Head and Neck Cancer Group (TTCC) 2503 Trial.
Authors:	Hitt R; Medical Oncology Department, Hospital Universitario Severo Ochoa, Avda. de Orellana, s/n, 28911, Leganés (Madrid), Spain. rhitt@telefonica.net., Iglesias L; Medical Oncology Department, Hospital Universitario, 12 de Octubre, Madrid, Spain., López-Pousa A; Medical Oncology Department, Hospital de la Santa Creu i Sant Pau, Calalunya, Spain., Berrocal-Jaime A; Medical Oncology Department, Consorci Hospital General Universitari de Valencia, Valencia, Spain., Grau JJ; Medical Oncology Department, Hospital Clinic de Barcelona, Catalunya, Spain., García-Girón C; Medical Oncology Department, Hospital Universitario de Burgos, Castilla y León, Spain., Martínez-Trufero J; Medical Oncology Department, Hospital Universitario Miguel Servet, Aragón, Spain., Guix M; Medical Oncology Department, Hospital del Mar, Barcelona, Spain.; Cancer Research Program (CIBERONC), Institut Mar d Investigacions Mèdiques (IMM), Barcelona, Spain., Lambea-Sorrosal J; Medical Oncology Department, Hospital Clínico Lozano Blesa, Zaragoza, Spain., Del Barco-Morillo E; Medical Oncology Department, Hospital Universitario de Salamanca, Castilla y León, Spain.; Institute for Biomedical Research of Salamanca (IBSAL), Castilla y León, Spain., León-Vintró X; ENT Department, Hospital de la Santa Creu i Sant Pau, Catalunya, Spain., Cunquero-Tomas AJ; Medical Oncology Department, Consorci Hospital General Universitari de Valencia, Valencia, Spain., Baste N; Medical Oncology Department, Hospital Clinic de Barcelona, Catalunya, Spain., Ocaña A; Medical Oncology Department, Hospital Universitario de Salamanca, Castilla y León, Spain.; Institute for Biomedical Research of Salamanca (IBSAL), Castilla y León, Spain., Cruz-Hernández JJ; Medical Oncology Department, Hospital Universitario de Salamanca, Castilla y León, Spain.; Institute for Biomedical Research of Salamanca (IBSAL), Castilla y León, Spain.
Corporate Authors:	the Spanish Head and Neck Cancer Cooperative Group (TTCC)
Source:	Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico [Clin Transl Oncol] 2021 Apr; Vol. 23 (4), pp. 764-772. Date of Electronic Publication: 2020 Aug 14.
Publication Type:	Journal Article; Observational Study
Journal Info:	Publisher: Springer Italia Country of Publication: Italy NLM ID: 101247119 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1699-3055 (Electronic) Linking ISSN: 1699048X NLM ISO Abbreviation: Clin Transl Oncol Subsets: MEDLINE
Database:	MEDLINE Ultimate

Description
ISSN:	1699-3055
DOI:	10.1007/s12094-020-02467-8